Medicaid Policy: Approval Timeline for Tennessee’s 1115 Waiver Amendment Remains Uncertain, Could Be Complicated by Forthcoming Legislative Changes

Published on Jun 27, 2025

Tennessee is waiting on the Centers for Medicare and Medicaid Services (CMS) to approve an amendment to its Medicaid managed care program, TennCare III, that would authorize additional payments to hospitals that meet certain access and quality improvement benchmarks. While it remains to be seen how the new administration will handle Tennessee’s application, the fact that Congress is currently […]

Prosus/Just Eat Takeaway.com: Acquirer To Offer EC Divestiture Remedies, Sources Say

This article has been updated with a statement from Prosus. Prosus is offering to sell down its stake in food delivery platform Delivery Hero (ETR: DHER) to single digits in hopes of avoiding an...

Jul 18, 2025 Read Now >

Novo Nordisk: Company Did Not Report or Investigate Deaths Potentially Caused by Ozempic

Novo Nordisk (NVO) did not report multiple deaths that may have been caused by its blockbuster weight loss drug Ozempic to the FDA, according to an agency inspection report obtained by The Capitol...

Jul 15, 2025 Read Now >

Antitrust Agenda: DOJ Indicts Oak View Group CEO for Arena Bid Rigging; Low Efficacy of Post-Merger Divestitures Indicates Need for Stronger Enforcement, New Paper Concludes; Manufacturers Neglect of Repair Manuals and Materials Could Run Afoul of Right-to-Repair Laws

Live entertainment executive indicted on criminal bid-rigging charges. The Justice Department last Wednesday indicted Timothy Leiweke, the CEO of the live entertainment company Oak View Group (OVG),...

Jul 14, 2025 Read Now >

Medicaid Policy: Approval Timeline for Tennessee’s 1115 Waiver Amendment Remains Uncertain, Could Be Complicated by Forthcoming Legislative Changes

RELATED ARTICLES | Editor’s picks

Prosus/Just Eat Takeaway.com: Acquirer To Offer EC Divestiture Remedies, Sources Say

Novo Nordisk: Company Did Not Report or Investigate Deaths Potentially Caused by Ozempic

Antitrust Agenda: DOJ Indicts Oak View Group CEO for Arena Bid Rigging; Low Efficacy of Post-Merger Divestitures Indicates Need for Stronger Enforcement, New Paper Concludes; Manufacturers Neglect of Repair Manuals and Materials Could Run Afoul of Right-to-Repair Laws

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.